Elevance Health medium term targets in focus, shares trade near recent NYSE range

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-23, 21:14.

Elevance Health (US0367521038) remains one of the larger managed care names on the NYSE under the ticker ELV. The S&P 500 constituent has recently detailed medium term financial targets that frame its operations and capital allocation priorities for the coming years, according to current company statements and analyst summaries.

What the latest targets signal

Elevance Health positions its business on a multi-year algorithm of mid to high single-digit premium growth and double-digit adjusted earnings per share expansion, as summarized in recent investor materials and earnings commentary from April 2026. Company investor relations overview Management continues to emphasize disciplined medical cost trend management and productivity gains in its Carelon services platform as key operational levers.

In its first-quarter 2026 report, Elevance Health reported adjusted EPS of 12.58 US dollars for Q1 2026, exceeding consensus estimates of 10.74 US dollars by 1.84 US dollars, which underpins the earnings component of those targets. MarketBeat earnings summary for Elevance Health Revenue momentum has been supported by membership growth in government programs and commercial segments, alongside expansion in its services offerings.

Consensus views and peer comparison

Analyst services tracking Elevance Health, such as MarketBeat, describe a consensus view that still anticipates earnings growth into 2027 and 2028, with the shares trading at a valuation broadly in line with managed care peers like UnitedHealth Group and CVS Health based on current multiples. MarketBeat Elevance Health overview The stock’s role in the S&P 500 health care cohort keeps it in focus for large-cap US equity investors.

Recent price data show Elevance Health shares changing hands in the high 390 to just under 400 US dollar range on the NYSE during June 2026, with an indicative quote of 396.55 US dollars at 09:22 Eastern Time on 2026-06-23 according to financial data consolidators. FinancialData.net quote for ELV This keeps the stock near levels seen after the Q1 numbers while leaving room for analysts to reassess targets as new quarterly data arrive.

How Elevance Health makes its money

Elevance Health generates most of its revenue from health insurance premiums across commercial, Medicare and Medicaid plans in the United States, complemented by fee-based services in areas such as pharmacy benefit management, care delivery and data-driven health solutions under the Carelon brand family.

Where the shares trade today

The Elevance Health shares (US0367521038) traded on the NYSE at 396.55 US dollars as of 2026-06-23, 09:22 Eastern Time based on the latest available quote data.

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. Investors should conduct their own research and consider consulting a licensed financial advisor before making investment decisions.